Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5

    NEXT STORY
    VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
    PREV STORY
    ADMA Biologics to Present at Upcoming Investor Conferences
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Caladrius Biosciences Receives SAKIGAKE Expedited Review Designation in Japan for CLBS12 for Treating Critical Limb Ischemia

    author_avatar
    NASDAQ Market News

    Clene Reports Full Year 2020 Operating and Financial Highlights

    author_avatar
    NASDAQ Market News

    Tabula Rasa HealthCare’s DoseMeRx™ Integrates with The Sanford Guide

    author_avatar
    NASDAQ Market News